Lv11
52 积分 2025-09-29 加入
Efficacy and Safety of Carvedilol in Cirrhosis Patients With New-Onset Uncomplicated Ascites Without High-Risk Esophageal Varices (CARVE-AS Trial)
5小时前
已完结
Acute and chronic haemodynamic and renal effects of carvedilol in patients with cirrhosis
5天前
已完结
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial
17天前
已完结
Baveno VIII – Advancing Consensus in Portal Hypertension
1个月前
已完结
Baveno VIII – Advancing Consensus in Portal Hypertension
1个月前
已完结
Spleen stiffness measurement predicts decompensation and rules out high-risk oesophageal varices in primary biliary cholangitis
1个月前
已完结
Value of the Hepatic Venous Pressure Gradient to Monitor Drug Therapy for Portal Hypertension: A Meta-Analysis
3个月前
已完结
Hepatic Venous Pressure Measurement: An Old Test As A New Prognostic Marker in Cirrhosis?
3个月前
已完结
Hepatic venous pressure gradient: clinical use in chronic liver disease
3个月前
已完结
Spleen‐dedicated stiffness measurement performed well to rule out high‐risk varices in HBV‐related hepatocellular carcinoma
3个月前
已完结
皖公网安备34019202002308
